
Basic Protective Measures Against COVID-19
COVID-19 is a new strain of the common cold that has been p...
COVID-19 is a new strain of the common cold that has been p...
Bicalutamide (Casodex) is indicated for the treatment of prostate cancer. This medication is used with another drug, LHRH-type like goserelin and leuprolide. Prostate cancer happens in the prostate. It is a slight walnut-shaped gland in men that makes the seminal fluid nourishes and transports sperm. It usually grows slowly.
Bicalutamide (Casodex) competitively prevents the act of androgens. It is by binding to cytosol androgen receptors in the target tissue. Prostatic carcinoma is known to be androgen-sensitive. It also responds to the effect of androgen and eliminates the source of androgen.
When this medication is united with LHRH analog therapy, the suppression of serum testosterone made by the LHRH analog is not affected. Still, in clinical trials with Bicalutamide (Casodex) as a single agent for prostate cancer, it rises in serum testosterone and estradiol has been noted.
Bicalutamide (Casodex) is a non-steroidal androgen receptor inhibitor. Androgens are hormones that the adrenal gland is making and releasing. This medication blocks the action of male hormones in the prostate. This also slows the growth of cancer cells. Bicalutamide (Casodex) was approved by the Food and Drug Administration (FDA) in 1995.
How to use Bicalutamide (Casodex)?
The prescribed dosage will depend on your condition and response to the treatment.
This medication should be taken as one 50mg in the morning or evening. Take this at the same time each day. You may take this with or without food. Once the treatment has started, it should not be interrupted or stopped without consulting your doctor.
Let your doctor know if you have serious side effects like: